WallStreetZenWallStreetZen

NASDAQ: NTLA
Intellia Therapeutics Inc Stock Ownership - Who owns Intellia Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Intellia Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael P. DubeVP Chief Accounting Officer2024-10-022,012$19.01
$38.25kSell
Eliana ClarkEVP Chief Technical Officer2024-07-01405$22.93
$9.29kSell
Frank VerwielDirector2024-06-171,505$25.00
$37.63kSell
Eliana ClarkEVP Chief Technical Officer2024-03-04605$32.99
$19.96kSell
James BastaEVP General Counsel2024-03-042,297$32.99
$75.78kSell
Laura SepplorenzinoEVP Chief Scientific Officer2024-01-08667$29.38
$19.60kSell
Laura SepplorenzinoEVP Chief Scientific Officer2024-01-081,608$28.66
$46.09kSell
Laura SepplorenzinoEVP Chief Scientific Officer2024-01-035,532$29.46
$162.97kSell
Glenn GoddardEVP Chief Financial Officer2024-01-035,365$29.46
$158.05kSell
Eliana ClarkEVP Chief Technical Officer2024-01-034,301$29.46
$126.71kSell

1 of 2

NTLA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NTLA insiders and whales buy or sell their stock.

NTLA Shareholders

What type of owners hold Intellia Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC11.42%11,595,789$215.45MInstitution
Blackrock Inc9.45%9,597,607$178.32MInstitution
Vanguard Group Inc8.96%9,100,068$169.08MInstitution
Rachel E. Haurwitz5.51%5,593,846$103.93MInsider
Caribou Therapeutics Holdco LLC5.51%5,593,846$103.93MInsider
Deep Track Capital LP4.73%4,800,000$89.18MInstitution
State Street Corp4.29%4,362,780$81.06MInstitution
Novartis Institutes For Biomedical Research Inc4.28%4,352,295$80.87MInsider
Caribou Biosciences Inc3.93%3,994,355$74.22MInsider
Atlas Venture Associates Ix LP3.67%3,729,788$69.30MInsider

1 of 3

NTLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NTLA70.02%29.98%Net SellingNet Selling
KNSA49.56%9.88%Net SellingNet Selling
LGND15.86%84.14%Net SellingNet Selling
MIRM50.46%49.54%Net BuyingNet Buying
RXRX78.69%21.31%Net SellingNet Selling
View Top Biotech Stocks

Intellia Therapeutics Stock Ownership FAQ

Who owns Intellia Therapeutics?

Intellia Therapeutics (NASDAQ: NTLA) is owned by 88.67% institutional shareholders, 37.96% Intellia Therapeutics insiders, and 0.00% retail investors. Rachel E. Haurwitz is the largest individual Intellia Therapeutics shareholder, owning 5.59M shares representing 5.51% of the company. Rachel E. Haurwitz's Intellia Therapeutics shares are currently valued at $103.93M.

If you're new to stock investing, here's how to buy Intellia Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.